Page last updated: 2024-10-29

iohexol and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated

iohexol has been researched along with Diffuse Lymphocytic Lymphoma, Poorly-Differentiated in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yun, S1
Vincelette, ND1
Phan, T1
Anwer, F1
Baheti, AD1
Tirumani, SH1
Sewatkar, R1
Sachin, SS1
Shinagare, AB1
Ramaiya, NH1

Other Studies

2 other studies available for iohexol and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated

ArticleYear
Spontaneous tumour lysis syndrome associated with contrast dye iohexol use in mantle cell lymphoma.
    BMJ case reports, 2014, Jul-15, Volume: 2014

    Topics: Aged; Biopsy; Contrast Media; Diagnosis, Differential; Humans; Iohexol; Lymphoma, Mantle-Cell; Male;

2014
MDCT of extranodal mantle cell lymphoma: a single institute experience.
    Abdominal imaging, 2015, Volume: 40, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diatrizoate Meglumine; Female; Humans; Intestines; I

2015